Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/96445
Title: | Inhibition of influenza virus replication by oseltamivir derivatives | Authors: | Chan, RWY Tao, KP Ye, J Lui, KKY Yang, X Ma, C Chan, PKS |
Issue Date: | Feb-2022 | Source: | Pathogens, Feb. 2022, v. 11, no. 2, 237 | Abstract: | Characterized by the high morbidity and mortality and seasonal surge, the influenza virus (IV) remains a major public health challenge. Oseltamivir is commonly used as a first-line antiviral. As a neuraminidase inhibitor, it attenuates the penetration of viruses through the mucus on the respiratory tract and inhibits the release of virus progeny from infected cells. However, over the years, oseltamivir-resistant strains have been detected in the IV surveillance programs. Therefore, new antivirals that circumvent the resistant strains would be of great importance. In this study, two novel secondary amine derivatives of oseltamivir CUHK326 (6f) and CUHK392 (10i), which bear heteroaryl groups of M2-S31 proton channel inhibitors, were designed, synthesized and subjected to biological evaluation using plaque assay. Influenza A virus (A/Oklahoma/447/2008, H1N1), influenza B viruses (B/HongKong/CUHK33261/2012), an oseltamivir-resistant influenza A virus (A/HongKong/CUHK71923/2009, H1N1) and an oseltamivir-resistant influenza B virus (B/HongKong/CUHK33280/2012) were included in the antiviral effect assessment compared to oseltamivir carboxylate (OC). Both novel compounds significantly reduced the plaque size of seasonal IV A and B, and performed similarly to OC at their corresponding half-maximal inhibitory concen-tration (IC50). CUHK392 (10i) functioned more effectively than CUHK326 (6f). More importantly, these compounds showed an inhibitory effect on the oseltamivir-resistant strain under 10 nM with selective index (SI) of >200. | Keywords: | Influenza antiviral Influenza virus Oseltamivir derivatives Oseltamivir-resistant |
Publisher: | MDPI AG | Journal: | Pathogens | EISSN: | 2076-0817 | DOI: | 10.3390/pathogens11020237 | Rights: | © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). The following publication Chan, R. W., Tao, K. P., Ye, J., Lui, K. K., Yang, X., Ma, C., & Chan, P. K. (2022). Inhibition of Influenza Virus Replication by Oseltamivir Derivatives. Pathogens, 11(2), 237 is available at https://doi.org/10.3390/pathogens11020237. |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
pathogens-11-00237-v3.pdf | 906.31 kB | Adobe PDF | View/Open |
Page views
56
Last Week
1
1
Last month
Citations as of Oct 13, 2024
Downloads
25
Citations as of Oct 13, 2024
SCOPUSTM
Citations
7
Citations as of Oct 17, 2024
WEB OF SCIENCETM
Citations
6
Citations as of Oct 17, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.